5 insiders reported 11 Form 4 transactions for Genprex, Inc. (GNPX) over the past 18 months (most recent 2026-04-15). Recent activity: LONGNECKER BRENT M (Director) Sell 10 shares, LONGNECKER BRENT M (Director) Sell 8 shares, Berger Mark Stanley (Chief Medical Officer) Sell 7,168 shares, Confer Ryan M. (President, CEO and CFO) Sell 9,330 shares, Confer Ryan M. (President, CEO and CFO) Buy 45,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-15 | LONGNECKER BRENT M | Director | Sell | 10 | $12 |
| 2026-04-15 | LONGNECKER BRENT M | Director | Sell | 8 | $10 |
| 2026-02-27 | Berger Mark Stanley | Chief Medical Officer | Sell | 7,168 | $14,336 |
| 2026-02-27 | Confer Ryan M. | President, CEO and CFO | Sell | 9,330 | $18,660 |
| 2025-12-23 | Confer Ryan M. | President, CEO and CFO | Buy | 45,000 | $0 |
| 2025-12-23 | Moreno Toscano Jose Antonio | Director | Buy | 9,000 | $0 |
| 2025-12-23 | Wilson William R Jr. | Director | Buy | 9,000 | $0 |
| 2025-12-23 | Berger Mark Stanley | Chief Medical Officer | Buy | 28,500 | $0 |
| 2025-12-23 | LONGNECKER BRENT M | Director | Buy | 9,000 | $0 |
| 2025-07-01 | Berger Mark Stanley | Chief Medical Officer | Sell | 4,500 | $1,035 |
| 2025-07-01 | Confer Ryan M. | President, CEO and CFO | Sell | 5,775 | $1,328 |
来源：SEC Form 4 申报文件 · 截至 2026-04-15